Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1318
| Despition | Orexin A Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1666 | Human LGALS3 Protein, His (AC1666) | 5 µg | inquiry |
| ACPP-1796 | Human GAP43 Protein (AC1796) | 2 µg | inquiry |
| ACPP-1330 | PAX2 Blocking Peptide (AC1330) | 250 µg | inquiry |
| ACPP-1025 | Recombinant Human GPR56 Protein (6×His Tag) (AC1025) | 50 µg | inquiry |
| ACPP-1046 | Recombinant Mouse CD45 Protein (6×His Tag) (AC1046) | 50 µg | inquiry |
| ACPP-1443 | Human BSND Protein (AC1443) | 2 µg | inquiry |
| ACPP-1161 | Recombinant Human DLK-1 Protein (6×His Tag) (AC1161) | 50 µg | inquiry |
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
| ACPP-1210 | Alpha SNAP Blocking Peptide (AC1210) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.